SE455045B - Stabil, koncentrerad losning av cisplatin - Google Patents

Stabil, koncentrerad losning av cisplatin

Info

Publication number
SE455045B
SE455045B SE8101990A SE8101990A SE455045B SE 455045 B SE455045 B SE 455045B SE 8101990 A SE8101990 A SE 8101990A SE 8101990 A SE8101990 A SE 8101990A SE 455045 B SE455045 B SE 455045B
Authority
SE
Sweden
Prior art keywords
cisplatin
solution
polyethylene glycol
stable
sterile
Prior art date
Application number
SE8101990A
Other languages
English (en)
Swedish (sv)
Other versions
SE8101990L (sv
Inventor
M A Kapland
A P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8101990L publication Critical patent/SE8101990L/
Publication of SE455045B publication Critical patent/SE455045B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8101990A 1980-03-31 1981-03-27 Stabil, koncentrerad losning av cisplatin SE455045B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
SE8101990L SE8101990L (sv) 1981-11-13
SE455045B true SE455045B (sv) 1988-06-20

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101990A SE455045B (sv) 1980-03-31 1981-03-27 Stabil, koncentrerad losning av cisplatin

Country Status (30)

Country Link
JP (1) JPS56152415A (de)
KR (1) KR860000841B1 (de)
AR (1) AR225500A1 (de)
AT (1) AT370996B (de)
AU (1) AU541056B2 (de)
BE (1) BE888209A (de)
CA (1) CA1162479A (de)
CH (1) CH647481A5 (de)
CS (1) CS246051B2 (de)
DD (1) DD157762A5 (de)
DE (1) DE3112272A1 (de)
DK (1) DK158564C (de)
ES (1) ES500869A0 (de)
FI (1) FI70670C (de)
FR (1) FR2480605A1 (de)
GB (1) GB2074028B (de)
GR (1) GR72769B (de)
HU (1) HU183379B (de)
IE (1) IE51070B1 (de)
IL (1) IL62517A (de)
IT (1) IT1170838B (de)
LU (1) LU83270A1 (de)
NL (1) NL8101531A (de)
NO (1) NO156675C (de)
NZ (1) NZ196519A (de)
PH (1) PH17152A (de)
PT (1) PT72774B (de)
SE (1) SE455045B (de)
SU (1) SU1056893A3 (de)
ZA (1) ZA812084B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (de) 1984-05-11
DE3112272C2 (de) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (de) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (de) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
US4322391A (en) Process for the preparation of microcrystalline cisplatin
US4310515A (en) Pharmaceutical compositions of cisplatin
SE464061B (sv) Framstaellning av stabil, frystorkad cis-platina(ii)-diammindiklorid ur en vatten-alkoholloesning
SE455045B (sv) Stabil, koncentrerad losning av cisplatin
CA2079482C (en) Antiviral compositions and method for their use
SE445172B (sv) Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
JP3879940B2 (ja) 塩酸ファスジル注射剤
Mann et al. β β'β"-Triaminotriethylamine and its complex metallic compounds
JPH03130226A (ja) １つより多いエチレンイミン基を有する抗新生物性化合物用の安定な製薬学的配合及び方法
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
US3322627A (en) Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
AU623632B2 (en) A solution of carboplatin
CN110507607A (zh) 苯海拉明肾素口服液及其制备方法和用途
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
EP1691813B1 (de) Gebrauchsfertige, sterile, stabile injektionslösung von 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amin-1h-purin-6(9h)-on; geschlossenes system zur verpackung der lösung, verfahren zur eliminierung von alkalischen resten von 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amin-1h-purin-6(9h)-on-kristallen,
IE63972B1 (en) Stable 5-flourouracil compositions
IL23611A (en) Insulin preparations
DK157484B (da) Fremgangsmaade til fremstilling af et cisplatin-praeparat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8101990-3

Effective date: 19941010

Format of ref document f/p: F